Heilongjiang Shenge Pharmaceutical Co., Ltd – Trademark Portfolio

Entity Type: 99

Heilongjiang Shenge Pharmaceutical Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SHENGE. The owner is based in Qiqihaer Heilongjiang.

No.1 Junmin Hutong

Junxiao Street, Jianhua District

Qiqihaer Heilongjiang 161006 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SHENGE
SHENGE
Registered 2021

Trademark Classifications

Heilongjiang Shenge Pharmaceutical Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Heilongjiang Shenge Pharmaceutical Co., Ltd have?

Heilongjiang Shenge Pharmaceutical Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Heilongjiang Shenge Pharmaceutical Co., Ltd file in?

Heilongjiang Shenge Pharmaceutical Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Heilongjiang Shenge Pharmaceutical Co., Ltd's most well-known trademarks?

Heilongjiang Shenge Pharmaceutical Co., Ltd's registered trademark portfolio includes well-known marks such as SHENGE. These are among 1 currently registered trademark in the portfolio.

What is Heilongjiang Shenge Pharmaceutical Co., Ltd's trademark registration success rate?

Heilongjiang Shenge Pharmaceutical Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.